Amoxicillin and Clavulanate Oral Presentations Shortage

• • Amoxicillin and Clavulanate oral tablet, Hikma, 875 mg/125 mg, 20 count, NDC 00143-9249-20
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6139-57
  • Amoxicillin and Clavulanate oral tablet, Sandoz, 875 mg / 125 mg, 100 count, NDC 00781-1852-01 - discontinued
  • Amoxicillin and Clavulanate oral powder for suspension, Teva, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-2279-73
  • Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00093-8675-75
  • Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00093-8675-78
  • Amoxicillin and Clavulanate oral tablet, Teva, 200 mg/28.5 mg, 20 count, NDC 00093-2270-34
  • Amoxicillin and Clavulanate oral tablet, Teva, 400 mg/57 mg, 20 count, NDC 00093-2272-34

• • Aurobindo refuses to provide availability information.
  • Hikma did not provide a reason for the shortage.
  • Micro Labs was not available to provide information.
  • Sandoz has amoxicillin and clavulanate oral presentations available.
  • Teva did not provide a reason for the shortage.
  • US Antibiotics has amoxicillin and clavulanate oral suspension available.
  • Wockhardt discontinued amoxicillin and clavulanate oral presentations in October 2024.

• • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00143-9981-01
  • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 50 mL bottle, 1 count, NDC 00143-9981-50
  • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9981-75
  • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00143-9982-01
  • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 50 mL bottle, 1 count, NDC 00143-9982-50
  • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9982-75
  • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00143-9853-16
  • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00143-9853-24
  • Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9853-75
  • Amoxicillin and Clavulanate oral extended release tablet, Sandoz, 1000 mg / 62.5 mg, 28 count, NDC 00781-1943-82
  • Amoxicillin and Clavulanate oral extended release tablet, Sandoz, 1000 mg / 62.5 mg, 40 count, NDC 00781-1943-39
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6102-46
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 50 mL bottle, 1 count, NDC 00781-6102-52
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6102-57
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6104-46
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 50 mL bottle, 1 count, NDC 00781-6104-52
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6104-57
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00781-6139-54
  • Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00781-6139-48
  • Amoxicillin and Clavulanate oral tablet, Sandoz, 250 mg / 125 mg, 30 count, NDC 00781-1874-31
  • Amoxicillin and Clavulanate oral tablet, Sandoz, 500 mg / 125 mg, 20 count, NDC 00781-1831-20
  • Amoxicillin and Clavulanate oral tablet, Sandoz, 500 mg / 125 mg, 100 count, NDC 00781-1831-01
  • Amoxicillin and Clavulanate oral tablet, Sandoz, 875 mg / 125 mg, 20 count, NDC 00781-1852-20
  • Amoxicillin and Clavulanate oral powder for suspension, Teva, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-2277-73
  • Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00093-8675-74
  • Amoxicillin and Clavulanate oral tablet, Teva, 500 mg/125 mg, 20 count, NDC 00093-2274-34
  • Amoxicillin and Clavulanate oral tablet, Teva, 875 mg/125 mg, 20 count, NDC 00093-2275-34
  • Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 81964-0203-69
  • Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 81964-0203-54
  • Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 81964-0203-51

Estimated Resupply Dates

• • Hikma has amoxicillin and clavulanate 875 mg/125 mg tablets on allocation.
  • Teva has amoxicillin and clavulanate 400 mg/5 mL - 57 mg/5 mL in 100 mL bottles and 600 mg/5 mL - 42.9 mg/5 mL in 75 mL and 125 mL bottles on back order and the company estimates a release date in late-August 2025.